RU2017131253A - Способы получения фторкетолидов - Google Patents

Способы получения фторкетолидов Download PDF

Info

Publication number
RU2017131253A
RU2017131253A RU2017131253A RU2017131253A RU2017131253A RU 2017131253 A RU2017131253 A RU 2017131253A RU 2017131253 A RU2017131253 A RU 2017131253A RU 2017131253 A RU2017131253 A RU 2017131253A RU 2017131253 A RU2017131253 A RU 2017131253A
Authority
RU
Russia
Prior art keywords
formula
compound
derivative
base
salt
Prior art date
Application number
RU2017131253A
Other languages
English (en)
Russian (ru)
Inventor
Дэвид Юджин ПЕРЕЙРА
Стефан Е. ШНАЙДЕР
Кешав ДЭО
Original Assignee
Семпра Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Семпра Фармасьютикалз, Инк. filed Critical Семпра Фармасьютикалз, Инк.
Publication of RU2017131253A publication Critical patent/RU2017131253A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
RU2017131253A 2015-03-06 2016-03-05 Способы получения фторкетолидов RU2017131253A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562129305P 2015-03-06 2015-03-06
US62/129,305 2015-03-06
PCT/US2016/021085 WO2016144833A1 (en) 2015-03-06 2016-03-05 Processes for preparing fluoroketolides

Publications (1)

Publication Number Publication Date
RU2017131253A true RU2017131253A (ru) 2019-04-08

Family

ID=56880477

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017131253A RU2017131253A (ru) 2015-03-06 2016-03-05 Способы получения фторкетолидов

Country Status (19)

Country Link
US (2) US20180044365A1 (enExample)
EP (1) EP3265100A4 (enExample)
JP (1) JP6773672B2 (enExample)
KR (1) KR20170133377A (enExample)
CN (1) CN107405355A (enExample)
AU (1) AU2016230027A1 (enExample)
BR (1) BR112017019176A2 (enExample)
CA (1) CA2978731A1 (enExample)
CL (1) CL2017002255A1 (enExample)
CO (1) CO2017010143A2 (enExample)
HK (1) HK1247097A1 (enExample)
IL (1) IL254306A0 (enExample)
MX (2) MX2017011454A (enExample)
PE (1) PE20180219A1 (enExample)
RU (1) RU2017131253A (enExample)
SG (2) SG10201908248PA (enExample)
TW (1) TW201638102A (enExample)
WO (1) WO2016144833A1 (enExample)
ZA (1) ZA201706505B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3668282A (en) * 1970-05-08 1972-06-06 Stauffer Chemical Co Stabilized mixture employing n-(beta-0,0-dialkyldithiophosphoryl) aryl sulfonamides
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
US7595300B2 (en) * 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
AU2008316830B2 (en) * 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US8376805B2 (en) * 2008-07-24 2013-02-19 Ideo Llc Printable pre-sewn stuffed toy composite sheets
CN103619849B (zh) * 2011-03-01 2016-05-25 沃克哈特有限公司 酮内酯中间体的制备方法
WO2014152326A1 (en) * 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) * 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
EP4095146A1 (en) * 2013-04-04 2022-11-30 President And Fellows Of Harvard College Macrolides and methods of their preparation and use

Also Published As

Publication number Publication date
CA2978731A1 (en) 2016-09-15
KR20170133377A (ko) 2017-12-05
JP6773672B2 (ja) 2020-10-21
WO2016144833A1 (en) 2016-09-15
CN107405355A (zh) 2017-11-28
CO2017010143A2 (es) 2018-02-28
US20210070797A1 (en) 2021-03-11
HK1247097A1 (zh) 2018-09-21
BR112017019176A2 (pt) 2018-04-24
TW201638102A (zh) 2016-11-01
US20180044365A1 (en) 2018-02-15
AU2016230027A1 (en) 2017-09-28
CL2017002255A1 (es) 2018-05-11
EP3265100A4 (en) 2019-01-09
EP3265100A1 (en) 2018-01-10
MX2017011454A (es) 2018-01-23
SG11201707215XA (en) 2017-10-30
JP2018508537A (ja) 2018-03-29
IL254306A0 (en) 2017-11-30
PE20180219A1 (es) 2018-01-31
MX2020007742A (es) 2020-09-25
SG10201908248PA (en) 2019-10-30
ZA201706505B (en) 2021-04-28

Similar Documents

Publication Publication Date Title
JP2015524409A5 (enExample)
RU2015102723A (ru) Получение 2-(5-бром-4-(4-циклопропилнафталин-1-ил)-4h-1,2,4-триазол-3-илтио)уксусной кислоты
IL292754B1 (en) Synthesis of n,n-dimethyltryptamine-type compounds
MY150289A (en) Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof
AR079752A1 (es) Prodrogas de sales de amonio cuaternario
AR070950A1 (es) Compuestos derivados de amina, composiciones farmaceuticas de ellos, compuestos inhibidores de produccion de 11-cis-retinol y metodos para tratar enfermedades y trastornos oftalmicos
AR088296A1 (es) Citramida de rasagilina, proceso de preparación y composicion farmaceutica
RU2018111201A (ru) Фунгицидная композиция для применения в сельском хозяйстве и садоводстве
AR083069A1 (es) Analogos de nucleotidos sustituidos
MX2014015501A (es) Carboxamidas heterociclicas fungicidas.
AR044874A1 (es) Derivados de 4- cianopirazol-3 - carboxamida, su preparacion y su aplicacion en terapeutica
EA201990455A1 (ru) КОНДЕНСИРОВАННОЕ ТРИЦИКЛИЧЕСКОЕ ПРОИЗВОДНОЕ γ-АМИНОКИСЛОТЫ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКОЕ ПРИМЕНЕНИЕ
JP2018508537A5 (enExample)
RU2016123144A (ru) Сложноэфирное хиральное соединение (n-замещенный имидазол)-карбоновой кислоты, содержащее простую эфирную боковую цепь, его получение и применение
RU2018106948A (ru) Способ получения замещенных производных 3-(2-анилино-1-циклогексил -1н-бензимидазол-5-ил)пропановой кислоты
JP2019535723A5 (enExample)
BR112017018580A2 (pt) p-toluenossulfonato para inibidor de mek quinase, e forma cristalina do mesmo e método de preparação para tal
RU2017123537A (ru) Средство для деформирующей обработки волос
JP2013537240A5 (enExample)
RU2016106125A (ru) Соли дасатиниба в кристаллической форме
RU2014124531A (ru) (1r,4r) 7-оксо-2-азабицикло[2.2.2]окт-5-ен и его производные
RU2019127038A (ru) N1-(4-(5-(циклопропилметил)-1-метил-1h-пиразол-4-ил)пиридин-2-ил)циклогексан-1,4-диаминовые производные и родственные соединения в качестве ингибиторов сk1 и/или irak1 для лечения рака
RU2016116036A (ru) Производное циклического амина и его фармацевтическое применение
AR072772A1 (es) Procedimiento de preparacion de combretastatina y uso del mismo
RU2015155032A (ru) Тилозиновые производные и способ их получения